Skip to content

Comparison of Two Analgesic Strategies After Scheduled Caesarean

Comparison of Two Analgesic Strategies After Scheduled Caesarean : Block of the Lumbar Region With Ropivacaine Versus Intrathecal Morphine

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04755712
Enrollment
104
Registered
2021-02-16
Start date
2021-03-22
Completion date
2022-10-12
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Brief summary

To demonstrate the superiority of square lumbar block to ropivacaine compared to intrathecal morphine in the efficacy of postoperative analgesia following scheduled caesarean.

Detailed description

Interventional, comparative, randomized, controlled study versus reference therapeutic strategy, in 2 parallel groups, double-blind (patient and evaluator), single-center, aiming to demonstrate the superiority of ropivacaine in square lumbar block versus intrathecal morphine, on the efficacy of post-operative analgesia, following a scheduled caesarean.

Interventions

DRUGRachianesthesia

Administration of different anesthesia drugs in accordance with the courant practice (mixture of bupivacaine and sufentanil)

Subcutaneous injection of Sodium chloride at the usual quadratum lumburum block 2 (QLB2) injection site under ultrasound (sham-QLB2).

DRUGMorphine

Morphine via pump (patient controlled analgesia)

Sponsors

GCS Ramsay Santé pour l'Enseignement et la Recherche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient to undergo a scheduled caesarean under spinal anesthesia, for the birth of a term baby with a Pfannenstiel-type incision; * Patient in good health ; * Patient able to understand the information related to the study, read the information leaflet and agree to sign the consent form.

Exclusion criteria

* Pregnancy less than 37 weeks with amenorrhea; * Multiple pregnancy; * Fetal pathology known at the time of inclusion; * Body mass index\> 45 kg / m²; * History of scoliosis or spine surgery; * History of chronic pain associated with taking opiates, neuropathic pain, neurological pathology; * Preoperative anemia (blood hemoglobin \<9 g / dL); * Hypersensitivity to ropivacaine or other local anesthetics with amide bond; * Hypersensitivity to morphine or opioids;

Design outcomes

Primary

MeasureTime frameDescription
Cumulative quantity of morphine received postoperatively via pump1 dayThe main objective of the study is to demonstrate the superiority of square lumbar block to ropivacaine (quadratum lumburum block 2 - QLB2) in comparison to intrathecal morphine in the efficacy of postoperative analgesia following a scheduled Caesarean.

Secondary

MeasureTime frameDescription
Characteristics of postoperative pain using a visual analogic scale2 daysEvaluate the characteristics of postoperative pain in both groups with the use of a visual analog scale
Side effects of the two analgesic strategies2 daysEvaluate the side effects of the two analgesic strategies reported in a case report form
Cumulative quantity of morphine received postoperatively via pump2 daysDemonstrate the superiority of square lumbar block to ropivacaine (quadratum lumburum block 2 - QLB2) in comparison to intrathecal morphine in the efficacy of postoperative analgesia following a scheduled Caesarean.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026